Related references
Note: Only part of the references are listed.RNAscope A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded Tissues
Fay Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
High-Risk Human Papillomavirus E6/E7 mRNA Detection by a Novel In Situ Hybridization Assay Strongly Correlates With p16 Expression and Patient Outcomes in Oropharyngeal Squamous Cell Carcinoma
Odey C. Ukpo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Quantitative Determination of Estrogen Receptor, Progesterone Receptor, and HER2 mRNA in Formalin-fixed Paraffin-embedded Tissue-A New Option for Predictive Biomarker Assessment in Breast Cancer
Berit Maria Mueller et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2011)
Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor-Positive Breast Cancer
Chungyeul Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather Than Percentage of Positive Cells
Allison W. Welsh et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Specific Regulation of NRG1 Isoform Expression by Neuronal Activity
Xihui Liu et al.
JOURNAL OF NEUROSCIENCE (2011)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
C. Davies et al.
LANCET (2011)
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Munir R. Tanas et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Adenosquamous Carcinoma of the Head and Neck: Relationship to Human Papillomavirus and Review of the Literature
Ramya P. Masand et al.
HEAD & NECK PATHOLOGY (2011)
Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
Mitch Dowsett et al.
CLINICAL CANCER RESEARCH (2008)
Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
Maureen Cronin et al.
CLINICAL CHEMISTRY (2007)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression pro-filing study
Yun Gong et al.
LANCET ONCOLOGY (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immmocytochemical assay, and northern blot: a comparison
M Lacroix et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
